ORLANDO, Fla.–(BUSINESS WIRE)–Lit Thinking, a company dedicated to biosecurity innovation, announced the launch of the Visium Vanguard Program, a groundbreaking initiative offering 50 select facilities the opportunity to experience the transformative benefits of Visium Far-UVC technology—completely free.
Visium represents a new era in how facilities reduce the risk of pathogen transmission, using cutting-edge autonomous technology to create operational resiliency and strengthen defenses against everything from seasonal outbreaks to future pandemics and biosecurity threats. The Visium Vanguard program invites participants from a variety of industries including healthcare, dental, education, sports, government and other commercial environments to trial this revolutionary solution with no upfront cost.
Visium is a ceiling-mounted, UL-certified fixture that emits Far-UVC, a wavelength proven to inactivate up to 99.9% of airborne and surface pathogens even while people are present. It’s safe, effective, and designed for real-world environments requiring continuous pathogen mitigation without disruption. Additionally, Visium is engineered for exceptional energy efficiency, providing sustainable and cost-effective sanitization without increasing a facility’s energy expenses.
Organizations accepted into the Visium Vanguard program will:
- Receive a zero-dollar sales proposal with full installation guidelines and support.
- Participate in pre- and post-installation swab testing to validate results.
- Collaborate in a case study to demonstrate the real-world impact of Visium.
At the conclusion of the pilot, participants will receive exclusive pricing incentives to extend Visium’s benefits across their facilities.
“Airborne transmission is a major driver of infections, yet it’s been largely unaddressed in most environments,” says John Rajchert, CEO of Lit Thinking. “Visium fills that critical gap—operating continuously to inactivate bacteria, viruses and fungi in real time. With 36,000 flu deaths and nearly 100,000 hospital-acquired infections annually in the U.S., scientists have been sounding the alarm: we need to do more. Visium gives facilities and businesses the means to act—right now.”
“When you consider the impending threat of another global pandemic either natural or man-made, the time to deploy this technology is now,” comments Lit Thinking Chief Science Officer, Dr Janet Price. “We are excited to offer the chance to experience the benefits of continuous sanitization and see the impact of this cutting-edge technology firsthand.”
Through Visium, facilities are empowered to build a more resilient, energy-efficient, and sustainable Infection Prevention infrastructure that operates without human intervention. This innovative technology enhances safety, strengthens biosecurity, and reduces the real and significant risks posed by airborne pathogens.
Visium is already trusted by leading institutions across healthcare, commercial offices, higher education, and early-learning centers. Notable installations include Roger Williams University, Lake Erie College of Osteopathic Medicine, and Mount Sinai’s Long COVID Clinic in New York City. These installations demonstrate the versatility and critical importance of Visium technology in both everyday and high-risk environments.
Interested organizations can learn more and register at https://litthinking.com/visium-vanguard/.
About Lit Thinking
Lit Thinking is a private technology firm dedicated to transforming indoor environments with innovative Far-UVC technology that helps healthcare and other industries create safer, healthier spaces. By enabling continuous pathogen inactivation, Visium supports the building of resilient, energy-efficient, and sustainable infection prevention infrastructures. With deep expertise in semiconductor R&D and cutting-edge research, Lit Thinking is leading the way in creating biosecurity solutions that improve the safety and well-being of indoor environments.
Contacts
Media Contact:
SRK Strategies
Leah
[email protected]
